The American Society for Clinical Investigation is proud to present the ASCI Scientific Sessions: a monthly spotlight on distinguished investigators and their contributions to the field of biomedical research. The Scientific Sessions are free and open to all, with a goal to create a space for our community, beyond our annual meeting, to gather and celebrate discovery.

October 20, 2021, 1-2 pm Eastern:

Daniel J. Drucker, MD
“Evolving mechanisms and clinical indications for incretin-based therapies”

Dr. Drucker is currently Professor of Medicine and Molecular and Medical Genetics, and Laboratory Medicine and Pathobiology at the University of Toronto. He holds the Banting and Best Diabetes Centre-Novo Nordisk Chair in Incretin Biology. Dr. Drucker was elected to the ASCI in 1995 (see profile).

Dr. Drucker is the recipient of numerous awards: the Claude Bernard Medal and Lecture from the European Association for the Study of Diabetes, the Banting Medal for Scientific Achievement from the American Diabetes Association, the Manpei Suzuki International Prize for Diabetes Research, the Rolf Luft Award from the Karolinska Institute, the ASCI | Harrington Prize for Innovation in Medicine (shared with Drs. Joel F. Habener and Jens J. Holst), the Transatlantic Medal of the British Endocrine Society, and the Canada Gairdner International Award. Dr. Drucker is an Officer of the Order of Canada and a Fellow of the Royal Society of London.

This event will be moderated by Rexford S. Ahima, MD, PhD. Dr. Ahima, 2018-2022 Editor of the Journal of Clinical Investigation, is Director of the Division of Endocrinology, Diabetes and Metabolism, Bloomberg Distinguished Professor of Diabetes in the Schools of Medicine, Public Health and Nursing, and the leader of the Johns Hopkins Diabetes Initiative at Johns Hopkins University School of Medicine. Dr. Ahima is a member of the National Academy of Medicine, the Association of American Physicians, and the ASCI (elected 2005).


September 15, 2021, 1-2 pm Eastern:

William G. Kaelin, Jr., MD
“von Hippel-Lindau Disease: A Bedside to Bench to Bedside Story”

Dr. Kaelin is currently a Howard Hughes Medical Institute Investigator, the Sidney Farber Professor of Medicine in the Department of Medicine at the Dana-Farber Cancer Institute, a professor at Harvard Medical School, and a professor and senior physician-scientist at Brigham and Women’s Hospital. Dr. Kaelin was elected to the ASCI in 1997 (see profile).

Dr. Kaelin is recipient of numerous awards including the 2019 Nobel Prize in Physiology or Medicine, shared with Sir Peter J. Ratcliffe and Dr. Gregg L. Semenza for their discoveries of how cells sense and adapt to oxygen availability; the 2016 Albert Lasker Basic Medical Research Award (with Sir Ratcliffe and Dr. Semenza); and the 2012 ASCI Stanley J. Korsmeyer Award (with Dr. Semenza).

This event was moderated by Hossein Ardehali, MD, PhD. Dr. Ardehali, the 2021-2022 ASCI President, is Professor of Medicine-Cardiology and Professor of Pharmacology; Director, Medical Scientist Training Program; and Director, Center for Molecular Cardiology, at the Northwestern University Feinberg School of Medicine.